Cogstate (FRA:C4B) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jun. 24, 2026)


FRA:C4B Cogstate Ltd FRA:C4B
69 GF Score
Price €1.68
GF Value €1.35
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cogstate Float Percentage Of Total Shares Outstanding?

Cogstate FRA:C4B +1.82% 69 Float Percentage Of Total Shares Outstanding is 0.00% as of Jun. 24, 2026. GuruFocus rates FRA:C4B with a GF Score™ of 69/100 and a GF Value™ of €1.35 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cogstate's float shares is 0.00 Mil. Cogstate's total shares outstanding is 169.88 Mil. Cogstate's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cogstate's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cogstate's Institutional Ownership is 6.82%.

FRA:C4B
69GF Score
Cogstate Ltd FRA:C4B
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogstate Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cogstate's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/169.88
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Cogstate (FRA:C4B) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jun. 24, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Cogstate and its competitors.
Is Cogstate's Float Percentage Of Total Shares Outstanding too high?
Cogstate's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Cogstate has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's Float Percentage Of Total Shares Outstanding compare to VEEV and BTSG?
Cogstate's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Healthcare Providers & Services company?
A good Float Percentage Of Total Shares Outstanding depends on the Healthcare Providers & Services industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Cogstate and its competitors. Cogstate's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (FRA:C4B) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.35, compared to a current price of €1.68 — trading 24.4% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Cogstate's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Cogstate (FRA:C4B), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cogstate (FRA:C4B) Overvalued in 2026?

Based on GuruFocus' analysis, Cogstate stock appears to be overvalued. The current stock price of €1.68 is trading 24.4% above its estimated GF Value™ of €1.35. GuruFocus considers Cogstate to be Modestly Overvalued.

Key valuation signals for FRA:C4B:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €1.35 vs. price of €1.68 (24.4% above fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the FRA:C4B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cogstate Business Description

Other Exchanges COGZF:USACGS:Australia
Address 367 Collins Street, Level 32, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
69GF Score

Get the complete analysis for FRA:C4B

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.68
Price
€1.35
GF Value